SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+13.07%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$174M
AUM Growth
+$174M
(+53%)
Cap. Flow
+$37.6M
Cap. Flow
% of AUM
21.63%
Top 10 Holdings %
Top 10 Hldgs %
68.58%
Holding
37
New
15
Increased
5
Reduced
10
Closed
7
Top Buys
| 1 |
Vanda Pharmaceuticals
VNDA
|
$19.1M |
| 2 |
Ligand Pharmaceuticals
LGND
|
$18.9M |
| 3 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$7M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$5.81M |
| 5 |
Aptevo Therapeutics
APVO
|
$3.51M |
Top Sells
Sector Composition
| 1 | Healthcare | 92.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanda Pharmaceuticals
VNDA
$279M
| $23.2M | 13.34% | 1,260,288 +1,039,440 | +471% | +$19.1M |
|
|
AMRN
2
Amarin Corp
AMRN
$311M
| $19.6M | 11.3% | 946,379 -153,621 | -14% | -$3.19M |
|
|
3
Ligand Pharmaceuticals
LGND
$3.15B
| $18.9M | 10.85% | +150,000 | New | +$18.9M |
|
|
NEOS
4
DELISTED
Neos Therapeutics, Inc
NEOS
| $11.8M | 6.77% | 4,511,504 +301,351 | +7% | +$787K |
|
|
APEN
5
DELISTED
Apollo Endosurgery, Inc.
APEN
| $9.65M | 5.55% | 2,580,518 +395,092 | +18% | +$1.48M |
|
|
BDSI
6
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $8.16M | 4.69% | 1,539,437 -2,442,430 | -61% | -$12.9M |
|
|
HTGM
7
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $7.09M | 4.08% | 2,835,786 +159,897 | +6% | +$400K |
|
|
ADMS
8
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $7M | 4.03% | +984,329 | New | +$7M |
|
9
Cumberland Pharmaceuticals
CPIX
$52.2M
| $6.98M | 4.02% | 1,201,975 -111,454 | -8% | -$648K |
|
|
ALIM
10
DELISTED
Alimera Sciences, Inc.
ALIM
| $6.87M | 3.95% | 6,483,610 -64,164 | -1% | -$68K |
|
|
11
Enanta Pharmaceuticals
ENTA
$180M
| $5.81M | 3.34% | +60,840 | New | +$5.81M |
|
|
ISEE
12
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.75M | 3.31% | 4,074,944 +2,643 | +0.1% | +$3.73K |
|
|
CTIC
13
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $3.88M | 2.23% | 4,000,000 -1,726,579 | -30% | -$1.68M |
|
|
OPNT
14
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $3.87M | 2.23% | 294,894 -63,066 | -18% | -$827K |
|
|
15
Aptevo Therapeutics
APVO
$5.39M
| $3.51M | 2.02% | +3,894,219 | New | +$3.51M |
|
|
VIVE
16
DELISTED
VIVEVE MED INC
VIVE
| $3.2M | 1.84% | 3,403,402 -15,000 | -0.4% | -$14.1K |
|
17
Xoma
XOMA
$392M
| $2.82M | 1.62% | +227,430 | New | +$2.82M |
|
|
FOMX
18
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.74M | 1.57% | 730,004 -563,173 | -44% | -$2.11M |
|
19
Emergent Biosolutions
EBS
$443M
| $2.36M | 1.36% | +46,800 | New | +$2.36M |
|
|
OXFD
20
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $2.19M | 1.26% | 127,224 -95,097 | -43% | -$1.64M |
|
21
Matinas BioPharma
MTNB
$10.1M
| $2.19M | 1.26% | +2,008,006 | New | +$2.19M |
|
|
AFMD
22
DELISTED
Affimed
AFMD
| $2.12M | 1.22% | 505,736 -208,343 | -29% | -$875K |
|
|
CHMA
23
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $1.56M | 0.9% | +300,000 | New | +$1.56M |
|
24
Verastem
VSTM
$569M
| $1.48M | 0.85% | +500,000 | New | +$1.48M |
|
|
IDXG
25
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
| $1.15M | 0.66% | +1,434,030 | New | +$1.15M |
|